Activity Overview
This educational activity is an archive of the live presentation held on February 7, 2026.
For more information about this educational activity, the faculty, and disclosures, please click here.
Target Audience
This educational activity is directed toward bone marrow transplant physicians, oncologists, nurses, advanced practice providers, pharmacists, fellows, and other health care providers—including dermatologists and pulmonologists—involved in the multidisciplinary care of patients with chronic GVHD.
Learning Objectives
At the conclusion of this activity, you should be better prepared to:
- Evaluate emerging GVHD prophylaxis strategies and their potential impact on reducing chronic GVHD burden following allo-HCT
- Interpret key clinical trial data supporting the use of approved and emerging agents for chronic graft-vs-host disease (cGVHD)
- Apply current evidence to select the most appropriate treatment option for patients with steroid-refractory cGVHD
- Identify and manage adverse events associated with systemic therapies for cGVHD to optimize tolerability and long-term outcomes
Carrie L. Kitko, MD
Ingram Professorship in Pediatric Oncology
Medical Director, Pediatric Stem Cell Transplant Program
Vanderbilt University Medical Center
Nashville, TN
Miguel-Angel Perales, MD
Chief, Adult Bone Marrow Transplantation Service
Attending Physician and Member
Division of Hematologic Malignancies, Department of Medicine
Memorial Sloan Kettering Cancer Center
New York, NY
Amandeep Salhotra, MD
Associate Professor, Division of Leukemia
Department of Hematology & Hematopoietic Cell Transplantation
City of Hope
Duarte, CA
Full faculty information and disclosures are available by reviewing the program workbook, linked here.
The staff of Physicians’ Education Resource®, LLC have no relevant financial relationships with ineligible companies.
PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.
Off-Label Disclosure and Disclaimer
This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here